Skip to main content
Caplight Logo









InnoUp Farma

InnoUp Farma

Private
SpainHealthcare & Life Scienceshttps://innoupfarma.com/

Last Round

VC Round

Feb 5, 2021

Total Funding Raised

$1.58M

Company Overview

InnoUp Farma is a biotechnology company that has developed a nanotechnology platform for oral drug delivery to improve the efficiency and safety of drugs for applications in oncology and immunotherapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

oral drug deliverynanoparticle drug deliverynanomedicineclinical-stage biotechIV to oral conversionoral immunotherapyOITfood allergy treatmentoral chemotherapyoral vaccinesdrug bioavailabilitypharma licensingoral paclitaxelsustained release formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InnoUp Farma Comparables

Compare InnoUp Farma with similar companies based on industry and business-model similarity.

InnoUp Farma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bionanoplus
78%
Nanomerics
77%
HaiHe Biopharma
77%

InnoUp Farma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 5, 2021
CrowdfundingOct 16, 2019
VC RoundApr 11, 2019
VC RoundNov 8, 2015

Key People

Founding team and executive leadership

Maite Agüeros

Co-Founder & CEO

Founding Team

Sara Gomez

Chief Technology Officer

Executive Team

InnoUp Farma Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2024

    Monthly visitors increased 153% MoM.

  • Feb 5, 2021

    $1.2M round with CDTI Innovation and Sodena

InnoUp Farma Filings

Explore SEC and related filing metadata, where available.

InnoUp Farma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InnoUp Farma's valuation, stock price, and market status.

Is InnoUp Farma a public or private company?

InnoUp Farma is a private company.

What is the current stock price of InnoUp Farma?

InnoUp Farma is a private company with no public stock price. No recent secondary market data is available.

How much is InnoUp Farma worth (valuation)?

Valuation information for InnoUp Farma is not publicly available.

Can I buy InnoUp Farma stock?

InnoUp Farma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was InnoUp Farma's last funding round?

InnoUp Farma's most recent funding round was VC Round on February 5, 2021.

Who are the main investors in InnoUp Farma?

Key investors in InnoUp Farma include Ministerio de Economía, Comercio y Empresa, Inveready, Empresa Nacional de Innovación, Center for Technological Development and Innovation, Capital Cell.

Will InnoUp Farma IPO soon?

No public IPO plans have been announced for InnoUp Farma.

How can I track InnoUp Farma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InnoUp Farma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSpain
Employee Range7
Year Founded2013
Last FundingFeb 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?